Jerry B. Gin - Aug 18, 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
Director
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Aug 18, 2022
Transactions value $
$35,740
Form type
4
Date filed
8/22/2022, 05:12 PM
Previous filing
Mar 3, 2022
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Purchase $17.9K +100K $0.18 100K Aug 18, 2022 Direct F1
transaction VTGN Common Stock Purchase $17.9K +100K $0.18 100K Aug 18, 2022 By Spouse F1
holding VTGN Common Stock 100K Aug 18, 2022 By Jermax, LLC F2
holding VTGN Common Stock 100K Aug 18, 2022 By Pegmax, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1772 to $0.1805, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F2 Jermax, LLC is wholly owned and controlled by the Reporting Person.
F3 Pegmax, LLC is wholly owned and controlled by the Reporting Person's spouse.